Risk of upper gastrointestinal tract events in risedronate users switched to alendronate.

Author: KouTzuyung D, MasudTahir, RalstonStuart H, SteinbuchMichael, Wick-UrbanBettina

Paper Details 
Original Abstract of the Article :
Upper gastrointestinal (GI) side effects are a known complication of therapy with oral aminobisphosphonates, but it is currently unclear if bisphosphonate type or formulation influences the risk of developing side effects. Here, we performed a retrospective cohort study to determine if patients who ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00223-010-9401-0

データ提供:米国国立医学図書館(NLM)

Switching bisphosphonates: A cautionary tale

Bisphosphonates are often used to treat osteoporosis, a condition that weakens bones. While these medications can be effective, they can sometimes cause side effects, especially in the upper gastrointestinal tract. This study investigates the potential risks associated with switching from risedronate to alendronate, two common bisphosphonates. It's like trying to find the best route through a desert, where each path has its own risks and rewards.

Switching bisphosphonates may increase GI side effects

The study found that switching from risedronate to alendronate is associated with an increased risk of gastrointestinal side effects, especially in patients with a history of GI problems. This information is important for doctors and patients to consider when making treatment decisions, as it highlights the potential downsides of switching bisphosphonates.

Be aware of potential side effects

It's crucial to be aware of the potential side effects of bisphosphonates, especially when switching between medications. Patients should talk to their doctor about any concerns they have and work together to make informed decisions about treatment. Just as a camel carefully chooses its path through the desert to avoid potential hazards, patients should be aware of the potential risks associated with their medications.

Dr.Camel's Conclusion

Switching medications can sometimes feel like navigating a new desert route. This study reminds us that not all paths are created equal! While bisphosphonates can be helpful, it's essential to be mindful of the potential risks, especially when switching medications. By working closely with their doctors, patients can make informed choices about their treatment and navigate the journey towards better health with more confidence.

Date :
  1. Date Completed 2011-01-06
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

20803291

DOI: Digital Object Identifier

10.1007/s00223-010-9401-0

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.